MedTrace Logo

The Influence of Atorvastatin on the Parameters of Inflammation and the Function of Left Ventricle

NCT01015144 · Status: COMPLETED · Type: OBSERVATIONAL

Last updated 2009-11-18

No results posted yet for this study

Summary

The aim of the study was to assess of the influence of atorvastatin on selected indicators of an inflammatory condition, function of the left ventricle and factors affecting the occurrence of undesired events like rehospitalizations and mortality in patients with dilated cardiomyopathy.

Conditions

  • Dilated Cardiomyopathy

Interventions

DRUG

Tulip

Patients were divided into two groups: A, who were administered atorvastatin 40 mg daily for two months and 10 mg for next 4 months; and group B, 4 who were treated according to current guidelines without statin therapy.

Sponsors & Collaborators

  • Medical University of Lodz

    lead OTHER

Principal Investigators

  • Agata Bielecka-Dabrowa, PhD · Department of Hypertension UM Lodz

  • Maciej Banach, Assoc. Prof. · Department of Hypertension UM Lodz

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-02-28
Primary Completion
2008-12-31
Completion
2009-02-28

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01015144 on ClinicalTrials.gov